Aton Biotech is a fast-growing CDMO company which is committed to enabling new biological drugs for clients with an integrated bio-pharmaceutical platform. Our service ranges from cell line development to clinical and end-to-end CDMO commercial manufacturing services, including development of mammalian expressed monoclonal antibodies, fusion proteins, bispecific antibodies, ADC, etc.
Aton Biotech has two R&D &manufacturing sites in Shanghai. Both are equipped with the latest technology and fully compliant with the cGMP requirement of the NMPA, EMA and FDA.